Methylenetetrahydrofolate reductase C677T polymorphism and factor V Leiden variant in Mexican women with preeclampsia/eclampsia

被引:37
作者
Dávalos, IP
Moran, MC
Martínez-Abundis, E
González-Ortiz, M
Flores-Martínez, SE
Machorro, V
Sandoval, L
Figuera, LE
Mena, JP
Oliva, JM
Tlacuilo-Parra, JA
Sánchez-Corona, J
Salazar-Páramo, M
机构
[1] CIBO, Inst Mexicano Seguro Social, Div Genet, Guadalajara 44330, Jalisco, Mexico
[2] Univ Guadalajara, CVCS, Guadalajara, Jalisco, Mexico
[3] Inst Mexicano Seguro Social, Unidad Invest Med & Epidemiol, Mexico City, DF, Mexico
[4] Univ Guadalajara, Ctr Univ Ciencias Salud, Dept Fisiol, Guadalajara, Jalisco, Mexico
关键词
C677T polymorphism; Factor V Leiden; preeclampsia/eclampsia;
D O I
10.1016/j.bcmd.2005.03.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The etiology of preeclampsia is still a matter of controversy. An association between hyperhomocysteinemia and preeclamptic patients has been described. A common missense mutation in the methylenetetrahydrofolate reductase (MTHFR) gene is associated with increased plasma homocysteine concentrations. In addition, the polymorphism of gene encoding for Factor V Leiden G1691A is associated with a prothrombotic state in heterozygous subjects. Both mutations in these thrombophilic proteins appear to have different prevalence in the general population and in patients with preeclampsia/eclampsia (PE/E). We studied single nucleotide polymorphisms for MTHFR C677T and coagulation Factor V Leiden in 33 Mexican patients with PE/E as a genetic risk factor for these diseases, comparing with a normotensive pregnant control group. The genotype and allele frequencies of MTHFR C677T and Factor V Leiden mutations between Mexican women with PE/E and healthy controls were not different. We conclude that these polymorphisms do not contribute in the etiology of PE/E as it has been reported in other populations. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:66 / 69
页数:4
相关论文
共 24 条
[1]   How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review [J].
Alfirevic, Z ;
Roberts, D ;
Martlew, V .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2002, 101 (01) :6-14
[2]   Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia [J].
D'Elia, AV ;
Driul, L ;
Giacomello, R ;
Colaone, R ;
Fabbro, D ;
Di Leonardo, C ;
Florio, P ;
Petraglia, F ;
Marchesoni, D ;
Damante, G .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2002, 53 (02) :84-87
[3]   The C677T polymorphism of the methylenetetrahydrofolate reductase gene in Mexican mestizo neural-tube defect parents, control mestizo and native populations [J].
Dávalos, IP ;
Olivares, N ;
Castillo, MT ;
Cantú, JM ;
Ibarra, B ;
Sandoval, L ;
Morán, MC ;
Gallegos, MP ;
Chakraborty, R ;
Rivas, F .
ANNALES DE GENETIQUE, 2000, 43 (02) :89-92
[4]  
DAVILA JP, 2001, GINECOL OBSTET MEX, V69, P6
[5]   The factor V Leiden mutation may predispose women to severe preeclampsia [J].
DizonTownson, DS ;
Nelson, LM ;
Easton, K ;
Ward, K .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (04) :902-905
[6]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[7]  
Grandone E, 1997, THROMB HAEMOSTASIS, V77, P1052
[8]   Prothrombin G20210A mutation: Is it associated with pre-eclampsia? [J].
Higgins, JR ;
Kaiser, T ;
Moses, EK ;
North, R ;
Brennecke, SP .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2000, 50 (04) :254-257
[9]  
Hughes EC, 1972, OBSTET GYNECOLOGIC T, P422
[10]   Methylenetetrahydrofolate reductase polymorphisms are not a risk factor for pre-eclampsia/eclampsia in Australian women [J].
Kaiser, T ;
Brennecke, SP ;
Moses, EK .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2000, 50 (02) :100-102